Schizophrenia 4

Common Name(s)

Schizophrenia 4

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Schizophrenia 4" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Schizophrenia 4" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Schizophrenia 4" returned 29 free, full-text research articles on human participants. First 3 results:

Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia.
 

Author(s): Giulio Genovese, Menachem Fromer, Eli A Stahl, Douglas M Ruderfer, Kimberly Chambert, Mikael Landén, Jennifer L Moran, Shaun M Purcell, Pamela Sklar, Patrick F Sullivan, Christina M Hultman, Steven A McCarroll

Journal: Nat. Neurosci.. 2016 Nov;19(11):1433-1441.

 

By analyzing the exomes of 12,332 unrelated Swedish individuals, including 4,877 individuals affected with schizophrenia, in ways informed by exome sequences from 45,376 other individuals, we identified 244,246 coding-sequence and splice-site ultra-rare variants (URVs) that were unique ...

Last Updated: 31 Dec 1969

Go To URL
IL-4, TGF-, NF-B and MPO levels in Patients with Treatment Resistant Schizophrenia.
 

Author(s): Şükrü Kartalcı, Lale Gönenir Erbay, Esra Porgalı Zayman, Önder Otlu, Aysun Bay Karabulut, Gülşen Kartalcı

Journal: Turk Psikiyatri Derg. 2016 ;27(3):170-175.

 

Schizophrenia is a chronic psychotic disorder in which genetics and environmental factors such as infection and the corresponding immune response play a role in the etiopathogenesis. The aim of this study was to compare some immune factors such as nuclear factor-B (NF-B) activation, ...

Last Updated: 31 Dec 1969

Go To URL
[Genetics of schizophrenia: is the complement component 4 a risk factor?].
 

Author(s): Dominique Campion

Journal: Med Sci (Paris). ;32(6-7):556-7.

 

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Schizophrenia 4" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 30 Nov 2017

Go to URL
[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis
 

Status: Not yet recruiting

Condition Summary: Schizophrenia

 

Last Updated: 22 Aug 2016

Go to URL
Predicting Antipsychotic Discontinuation in Psychosis
 

Status: Not yet recruiting

Condition Summary: Schizophrenia

 

Last Updated: 30 Aug 2016

Go to URL